Resource Guide

SYNGAP1 Resource Guide

Production and distribution of this resource are made possible by an educational grant from Greenwich Biosciences, acquired by Jazz Pharmaceuticals, a leader in the science, development, and commercialization of cannabinoid-based prescription medicines.

SYNGAP1 Natural History Study & Registry
(MRD5)

Join the SYNGAP1(MRD5) Natural History Study and Registry—a groundbreaking research initiative investigating gene changes linked to intellectual disability, epilepsy, and autism. Connect with experts, gain insights into diagnoses, and contribute to shaping the future of SYNGAP1 research and support.

SYNGAP1 Caregiver Resources

The SYNGAP1 Foundation, in partnership with CNF and Unite Us, aims to bridge gaps in support networks for SYNGAP1-related Disorders. Join us in building a stronger, more inclusive community, as we strive to provide invaluable resources and support for affected individuals and families nationwide.

Voice of SYNGAP1: EL-PFDD Meeting

Voice of the Patient & Caregiver Report: A Patient-Focused Drug Development Meeting for SYNGAP1-related Disorders